描述
Statistical analysis from research investigating a Novel Combination of High, comparing treatment groups and control conditions.
More Figures from This Paper
Figure 6
Experimental results examining a Novel Combination of High, with data points illustrating key findings related to omega-3 fatty acids have been shown to exert several beneficial effects in the prevention of cardiovascular and cereb.
chart
Figure 8
Measured parameters from a study evaluating a Novel Combination of High, contributing to the overall assessment of omega-3 fatty acids have been shown to exert several beneficial effects in the prevention of cardiovascular and cereb.
chart
Figure 9
Graphical representation of outcomes in a study of a Novel Combination of High, highlighting trends observed across experimental conditions.
chart
Figure 10
Quantitative data from a study on a Novel Combination of High, presenting measured outcomes relevant to the investigation of omega-3 fatty acids have been shown to exert several beneficial effects in the prevention of cardiovascular and cereb.
chart
Figure 11
Experimental results examining a Novel Combination of High, with data points illustrating key findings related to omega-3 fatty acids have been shown to exert several beneficial effects in the prevention of cardiovascular and cereb.
chart
Figure 12
Statistical analysis from research investigating a Novel Combination of High, comparing treatment groups and control conditions.
chartFigure 7
ChartSource Paper
A Novel Combination of High-Load Omega-3 Lysine Complex (AvailOm®) and Anthocyanins Exerts Beneficial Cardiovascular Effects.Cite This Figure
 > Source: Paola Di Pietro et al. "A Novel Combination of High-Load Omega-3 Lysine Complex (AvailOm®) and Anthocyan." *Antioxidants (Basel, Switzerland)*, 2022. PMID: [35624759](https://pubmed.ncbi.nlm.nih.gov/35624759/)
<figure> <img src="https://pdfs.citedhealth.com/figures/35624759/102.png" alt="Statistical analysis from research investigating a Novel Combination of High, comparing treatment groups and control conditions." /> <figcaption>Figure 7. Statistical analysis from research investigating a Novel Combination of High, comparing treatment groups and control conditions.<br> Source: Paola Di Pietro et al. "A Novel Combination of High-Load Omega-3 Lysine Complex (AvailOm®) and Anthocyan." <em>Antioxidants (Basel, Switzerland)</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35624759/">35624759</a></figcaption> </figure>